The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Educational reference only. Nothing on this page constitutes medical advice or encourages personal use of this compound. Always consult a qualified healthcare provider before any decision involving your health.

Meta-Z Kit

Meta-Z · Peptide Partners Meta-Z · DF05

C
Animal replicated
RouteInjectableGray-market only
C
Evidence grade: Animal replicated

Effect demonstrated in multiple animal studies; human data sparse or extrapolated. Grades summarize evidence quality, not whether a compound is appropriate, legal, or risk-free.

At a glance
What it is
MIC + amino acids + B vitamins — Metabolic Lipotropic Injection Blend — Lipotropic Injection Blend, Amino Acid Blend, Metabolic Support.
Why people use it
Used primarily for weight loss and mitochondrial health.
What the evidence supports
Meta-Z is used in the community primarily in the context of: body recomposition protocols (fat loss + lean mass preservation simultaneously); metabolic support during caloric restriction; energy and fatigue management during intense training periods; hepatic support when other injectable protocols are running. Typical community use: 0.5-2 mL subcutaneously or intramuscularly 1-3 times per week; most users inject 1-2 mL. Storage: room temperature (per Peptide Partners label); no refrigeration required. 10mL vials available; 50mL kit available.
Published literature
0human trials0human studies2animal1in vitro

Meta-Z is a proprietary injectable blend with component-level human evidence for nutrients such as inositol, taurine, carnitine, and B12, but no product-specific controlled human trial of the combined kit.

Evidence reality check
Human evidence
No human studies
0 observational; RCT evidence not present in corpus.
Preclinical base
3 lab signals
2 animal; 1 in-vitro/mechanistic.
Evidence snapshot
Meta-Z is used in the community primarily in the context of: body recomposition protocols (fat loss + lean mass preservation simultaneously); metabolic support during caloric restriction; energy and fatigue management during intense training periods; hepatic support when other injectable protocols are running. Typical community use: 0.5-2 mL subcutaneously or intramuscularly 1-3 times per week; most users inject 1-2 mL. Storage: room temperature (per Peptide Partners label); no refrigeration required. 10mL vials available; 50mL kit available.
From the chapter quick-reference block.
Properties
Injectable: extrapolated
Evidence
CAnimal replicated
The Nine Ingredients
B12 (Methylcobalamin) 1 mg/mL; Methionine 50 mg/mL; Inositol 100 mg/mL; Choline Bitartrate 400 mg/mL; Taurine 50 mg/mL; Leucine 20 mg/mL; L-Carnitine 500 mg/mL; L-Arginine 200 mg/mL; Alpha-Lipoic Acid 25 mg/mL. Three broad functional groups: (1) MIC lipotropic core (Methionine + Inositol + Choline); (2) Amino acid metabolic support (Taurine + Leucine + L-Carnitine + L-Arginine); (3) Cofactors (B12 + Alpha-Lipoic Acid).
The MIC Shot Tradition
MIC injections (Methionine + Inositol + Choline) have been used in weight loss clinics and medical practices for decades as lipotropic injections — compounds that support fat metabolism, liver function, and energy production. Meta-Z extends the basic MIC formula with amino acids (L-Carnitine, L-Arginine, Leucine, Taurine) and metabolic cofactors (Alpha-Lipoic Acid, B12) to create a more comprehensive metabolic support blend.
Evidence Framework
No clinical trial for this specific combination exists. The individual components have substantial independent evidence: Methylcobalamin B12 deficiency treatment (Grade A), L-Carnitine for fat oxidation and energy (Grade B multiple RCTs), L-Arginine for NO production and cardiovascular (Grade B), Alpha-Lipoic Acid antioxidant and metabolic (Grade B), Choline for liver and neurotransmission (Grade B), Taurine cardiovascular and exercise performance (Grade B). The combination as formulated: Grade E (vendor; no combination trial).
Simple view

Need the deep dive?

The default page keeps the decision layer visible first: summary, routes, evidence, and risks. Open the full report for mechanisms, chapter sections, citations, updates, and print/share controls.

Check interactions